Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Exposure of mammalian cells to ionizing radiation (IR) induces a complex array of cellular responses including cell cycle arrest and/or apoptosis. IR-induced G1 arrest has been shown to depend on the presence of the
tumor suppressor p53
, which acts as a transcriptional activator of several genes.
p53
also plays a role in the induction of apoptosis in response to DNA damage, and this pathway can be activated by both transcription-dependent and -independent mechanisms. Here we report the identification of a novel transcript whose expression is induced in response to IR in a
p53
-dependent manner, and that shows homology to the type 2C protein phosphatases. We have named this novel gene, wip1. In vitro, recombinant
Wip1
displayed characteristics of a type 2C phosphatase, including Mg2+ dependence and relative insensitivity to okadaic acid. Studies performed in several cell lines revealed that wip1 accumulation following IR correlates with the presence of wild-type
p53
. The accumulation of wip1 mRNA following IR was rapid and transient, and the protein was localized to the nucleus. Similar to waf1, ectopic expression of wip1 in human cells suppressed colony formation. These results suggest that
Wip1
might contribute to growth inhibitory pathways activated in response to DNA damage in a
p53
-dependent manner.
...
PMID:Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. 917 66
The human wildtype
p53
-induced phosphatase 1 (
Wip1
; GenBank symbol Ppm1d) gene encodes a type 2C protein phosphatase (PP2C) that is induced by ionizing radiation in a
p53
-dependent manner. We have cloned and sequenced the mouse
Wip1
gene and its encoded mRNA. The mouse
Wip1
gene is composed of six exons and spans over 36 kb of DNA. The mouse cDNA sequence predicts a 598-amino-acid protein with a molecular mass of roughly 66 kDa. Comparison of human and mouse
Wip1
sequences revealed 83% overall identity at the amino acid level. The 5'-flanking region of exon 1 had promoter elements characteristic of a housekeeping gene. The
Wip1
coding sequences share conserved functional regions with other PP2Cs from a diverse array of species. Expression of
Wip1
mRNA was detected ubiquitously in adult and embryonic tissues, though expression in the testis was much higher than in other tissues.
Wip1
has been mapped near the
p53
gene on mouse chromosome 11.
...
PMID:The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene. 1075 97
The stress-responsive p38 MAPK, when activated by genotoxic stresses such as UV radiation, enhances
p53
activity by phosphorylation and leads to cell cycle arrest or apoptosis. Here we report that a member of the protein phosphatase type 2C family,
Wip1
, has a role in down-regulating p38-
p53
signaling during the recovery phase of the damaged cells.
Wip1
was originally identified as a gene whose expression is induced following gamma or UV radiation in a
p53
-dependent manner. We found that
Wip1
is also inducible by other environmental stresses, such as anisomycin, H(2)O(2) and methyl methane sulfonate. UV-induction of
Wip1
requires p38 activity in addition to the wild-type
p53
.
Wip1
selectively inactivates p38 by specific dephosphorylation of its conserved threonine residue. Furthermore,
Wip1
expression attenuates UV-induced
p53
phosphorylation at Ser33 and Ser46, residues previously reported to be phosphorylated by p38.
Wip1
expression also suppresses both
p53
-mediated transcription and apoptosis in response to UV radiation. These results suggest that
p53
-dependent expression of
Wip1
mediates a negative feedback regulation of p38-
p53
signaling and contributes to suppression of the UV-induced apoptosis.
...
PMID:p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. 1110 24
The
Wip1
gene is a serine/threonine phosphatase that is induced in a
p53
-dependent manner by DNA-damaging agents. We show here that
Wip1
message is expressed in moderate levels in all organs, but is present at very high levels in the testes, particularly in the postmeiotic round spermatid compartment of the seminiferous tubules. We have confirmed that
Wip1
mRNA is induced by ionizing radiation in mouse tissues in a
p53
-dependent manner. To further determine the normal biological function of
Wip1
in mammalian organisms, we have generated
Wip1
-deficient mice.
Wip1
null mice are viable but show a variety of postnatal abnormalities, including variable male runting, male reproductive organ atrophy, reduced male fertility, and reduced male longevity. Mice lacking
Wip1
show increased susceptibility to pathogens and diminished T- and B-cell function. Fibroblasts derived from
Wip1
null embryos have decreased proliferation rates and appear to be compromised in entering mitosis. The data are consistent with an important role for
Wip1
in spermatogenesis, lymphoid cell function, and cell cycle regulation.
...
PMID:Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. 1180 1
Modulation of tumor suppressor activities may provide new opportunities for cancer therapy. Here we show that disruption of the gene Ppm1d encoding
Wip1
phosphatase activated the
p53
and p16 (also called Ink4a)-p19 (also called ARF) pathways through p38 MAPK signaling and suppressed in vitro transformation of mouse embryo fibroblasts (MEFs) by oncogenes. Disruption of the gene Cdkn2a (encoding p16 and p19), but not of Trp53 (encoding
p53
), reconstituted cell transformation in Ppm1d-null MEFs. In vivo, deletion of Ppm1d in mice bearing mouse mammary tumor virus (MMTV) promoter-driven oncogenes Erbb2 (also called c-neu) or Hras1 impaired mammary carcinogenesis, whereas reduced expression of p16 and p19 by methylation-induced silencing or inactivation of p38 MAPK correlated with tumor appearance. We conclude that inactivation or depletion of the
Wip1
phosphatase with resultant p38 MAPK activation suppresses tumor appearance by modulating the Cdkn2a tumor-suppressor locus.
...
PMID:Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. 1505 81
The wild-type
p53
-induced phosphatase PPM1D (or
Wip1
) is a serine/threonine phosphatase that is transcriptionally upregulated by
p53
following ultraviolet and ionizing radiation. PPM1D is an oncogene in transformation assays and is amplified or overexpressed in several human tumor types. Here, we demonstrate that PPM1D interacts with the nuclear isoform of uracil DNA glycosylase, UNG2, and suppresses base excision repair (BER). Point mutations that inactivate PPM1D phosphatase activity abrogate BER suppression, indicating that dephosphorylation by PPM1D is important for BER inhibition. We have identified UNG2 phosphorylation sites at threonines 6 and 126 that exhibit enhanced phosphorylation following UV irradiation. The UV-induced phosphorylated forms of UNG2 are more active than nonphosphorylated forms in mediating uracil-associated DNA cleavage. PPM1D dephosphorylation of UNG2 at phosphothreonine 6 is associated with reduced UNG2 activity. Thus, PPM1D may inhibit BER by dephosphorylating UNG2 to facilitate its inactivation after completion of DNA repair.
...
PMID:The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. 1532 77
The
p53
tumour suppressor functions as a transcriptional activator, and several
p53
-inducible genes that play a critical proapoptotic role have been described. Moreover,
p53
regulates the expression of various proteins participating in autoregulatory feedback loops, including proteins that negatively control
p53
stability (Mdm2 and Pirh2) or modulate stress-induced phosphorylation of
p53
on Ser-46 (p53DINP1 or
Wip1
), a key event for
p53
-induced apoptosis. Here, we describe a new systematic analysis of
p53
targets using oligonucleotide chips, and report the identification of dapk1 as a novel p53 target. We demonstrate that dapk1 mRNA levels increase in a
p53
-dependent manner in various cellular settings. Both human and mouse dapk1 genomic loci contain DNA sequences that bind
p53
in vitro and in vivo. Since dapk1 encodes a serine/threonine kinase previously shown to suppress oncogene-induced transformation by activating a p19ARF/
p53
-dependent apoptotic checkpoint, our results suggest that Dapk1 participates in a new positive feedback loop controlling
p53
activation and apoptosis.
...
PMID:dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. 1560 85
Wip1
, the wild-type
p53
-induced phosphatase, selectively dephosphorylates a threonine residue on p38 MAPK and mediates a negative feedback loop of the p38 MAPK-
p53
signaling pathway. To identify the substrate specificity of
Wip1
, we prepared a recombinant human
Wip1
catalytic domain (rWip1) and measured kinetic parameters for phosphopeptides containing the dephosphorylation sites in p38alpha and in a new substrate, UNG2. rWip1 showed properties that were comparable to those of PP2Calpha or full-length
Wip1
in terms of affinity for Mg(2+), insensitivity to okadaic acid, and threonine dephosphorylation. The substrate specificity constant k(cat)/K(m) for a diphosphorylated peptide with a pTXpY sequence was 6-8-fold higher than that of a monophosphorylated peptide with a pTXY sequence, while PP2Calpha showed a preference for monophosphorylated peptides. Although individual side chains before and after the pTXpY sequence of the substrate did not have a significant effect on rWip1 activity, a chain length of at least five residues, including the pTXpY sequence, was important for substrate recognition by rWip1. Moreover, the X residue in the pTXpY sequence affected affinity for rWip1 and correlated with selectivity for MAPKs. These findings suggest that substrate recognition by
Wip1
is centered toward a very narrow region around the pTXpY sequence. Three-dimension homology models of
Wip1
with bound substrate peptides were constructed, and site-directed mutagenesis was performed to confirm the importance of specific residues for substrate recognition. The results of our study should be useful for predicting new physiological substrates and for designing specific
Wip1
inhibitors.
...
PMID:Substrate specificity of the human protein phosphatase 2Cdelta, Wip1. 1580 22
The ATM (ataxia-telangiectasia mutated) and ATR (ataxia-telangiectasia and Rad3-related) kinases respond to DNA damage by phosphorylating cellular target proteins that activate DNA repair pathways and cell cycle checkpoints in order to maintain genomic integrity. Here we show that the oncogenic
p53
-induced serine/threonine phosphatase, PPM1D (or
Wip1
), dephosphorylates two ATM/ATR targets, Chk1 and
p53
. PPM1D binds Chk1 and dephosphorylates the ATR-targeted phospho-Ser 345, leading to decreased Chk1 kinase activity. PPM1D also dephosphorylates
p53
at phospho-Ser 15. PPM1D dephosphorylations are correlated with reduced cellular intra-S and G2/M checkpoint activity in response to DNA damage induced by ultraviolet and ionizing radiation. Thus, a primary function of PPM1D may be to reverse the
p53
and Chk1-induced DNA damage and cell cycle checkpoint responses and return the cell to a homeostatic state following completion of DNA repair. These homeostatic functions may be partially responsible for the oncogenic effects of PPM1D when it is amplified and overexpressed in human tumors.
...
PMID:PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. 1587 Feb 57
The eukaryotic cell has evolved a sophisticated set of cell signaling pathways that respond to DNA damage and efficiently repair that damage, protecting the cell from deleterious mutations, genomic instability, and transformation into a cancerous state. The ATM and ATR serine/threonine kinases are key sensors and transducers of DNA damage signals through phosphorylation of an array of signaling molecules that mediate all aspects of the DNA damage response, including enforcement of cell cycle checkpoints and direct repair of damaged DNA. We have shown that a type 2C serine/threonine phosphatase, PPM1D (or
Wip1
), can reverse the phosphorylation status of ATM/ATR-phosphorylated proteins
p53
and Chk1. This dephosphorylation of
p53
and Chk1 by PPM1D may result in reduced functional activities and is accompanied by suppression of DNA damage-induced cell cycle checkpoints and some aspects of DNA repair. Because PPM1D is transcriptionally activated by
p53
in response to DNA damage, PPM1D may serve as a critical component of a
p53
negative feedback regulatory loop since it now appears that PPM1D can inhibit
p53
activity by at least four different molecular mechanisms. This may explain why PPM1D is amplified and overexpressed in a subset of human breast cancers that invariably retain wild type
p53
alleles. We hypothesize that PPM1D is a homeostatic regulator of the DNA damage response that returns the cell to a more normal unstressed state following repair of the damage.
...
PMID:Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D. 1597 Jun 89
1
2
3
4
5
6
7
8
9
10
Next >>